1h Free Analyst Time
The global AI in inflammatory bowel disease market is forecasted to grow by USD 312.1 million during 2024-2029, accelerating at a CAGR of 33.3% during the forecast period. The report on the global AI in inflammatory bowel disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative for enhanced diagnostic accuracy and personalized treatment pathways, rapid advancements in AI capabilities and proliferation of big data in healthcare, and surging investment and strategic industry collaborations fueling innovation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global AI in inflammatory bowel disease market is segmented as below:
By Disease Type
- Ulcerative colitis
- Crohns disease
By Application
- Diagnosis assistance
- Treatment optimization
- Disease monitoring
By End-user
- Hospitals
- Specialty clinics
- Diagnostic laboratories
- Academic and research institutes
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the global AI in inflammatory bowel disease market covers the following areas:
- Global AI In Inflammatory Bowel Disease Market sizing
- Global AI In Inflammatory Bowel Disease Market forecast
- Global AI In Inflammatory Bowel Disease Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Five Forces Analysis
6 Market Segmentation by Disease Type
7 Market Segmentation by Application
8 Market Segmentation by End-user
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global global AI in inflammatory bowel disease market: AbbVie Inc., Bayer AG, BenevolentAI, Dova Health Intelligence Inc., F. Hoffmann La Roche Ltd., Insilico Medicine, International Business Machines Corp., Olympus Corp., Owkin Inc., PathAI Inc., Pfizer Inc., Siemens Healthineers AG, SingHealth Group., Takeda Pharmaceutical Co. Ltd., and Tempus Labs Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is evolution from diagnostic augmentation to predictive and prognostic intelligence."
According to the report, one of the major drivers for this market is the imperative for enhanced diagnostic accuracy and personalized treatment pathways.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Bayer AG
- BenevolentAI
- Dova Health Intelligence Inc.
- F. Hoffmann La Roche Ltd.
- Insilico Medicine
- International Business Machines Corp.
- Olympus Corp.
- Owkin Inc.
- PathAI Inc.
- Pfizer Inc.
- Siemens Healthineers AG
- SingHealth Group.
- Takeda Pharmaceutical Co. Ltd.
- Tempus Labs Inc.